TWD 26.25
(-8.7%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 688.73 Million TWD | -10.39% |
2022 | 768.6 Million TWD | 169.37% |
2021 | -1.1 Billion TWD | -10.57% |
2020 | -1 Billion TWD | -206.12% |
2019 | 944.33 Million TWD | 17.78% |
2018 | 801.79 Million TWD | 209.76% |
2017 | 258.84 Million TWD | 94.04% |
2016 | 133.39 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -820.06 Million TWD | 41.31% |
2024 Q1 | -1.39 Billion TWD | -302.86% |
2023 Q1 | 1.1 Billion TWD | 43.96% |
2023 Q2 | 1.42 Billion TWD | 28.89% |
2023 FY | 688.73 Million TWD | -10.39% |
2023 Q4 | 688.73 Million TWD | -56.53% |
2023 Q3 | 1.58 Billion TWD | 11.09% |
2022 Q4 | 768.6 Million TWD | -7.23% |
2022 Q2 | -2.45 Billion TWD | -148.25% |
2022 Q1 | -989.82 Million TWD | 10.67% |
2022 Q3 | 828.53 Million TWD | 133.72% |
2021 Q3 | -498.27 Million TWD | 0.0% |
2021 Q4 | -1.1 Billion TWD | -122.37% |
Name | Net Debt | Net Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 360.718% |
Level Biotechnology Inc. | -453.9 Million TWD | 251.736% |
Sagittarius Life Science Corp | -120.57 Million TWD | 671.233% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | 450.686% |
TaiMed Biologics Inc. | 499.84 Million TWD | -37.789% |
GlycoNex Incorporation | -148.56 Million TWD | 563.586% |
VBI | -25.31 Million TWD | 2820.556% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | -1610.465% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | -399.102% |
Visgeneer Inc. | 31.28 Million TWD | -2101.56% |
Mycenax Biotech Inc. | 207 Million TWD | -232.708% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 201.195% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 613.017% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | -10.812% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 1294.519% |
Enimmune corporation | -314.15 Million TWD | 319.232% |
TaiRx, Inc. | -147.86 Million TWD | 565.774% |
CHO Pharma, Inc. | -203.79 Million TWD | 437.96% |
EirGenix Inc. | -4.58 Billion TWD | 115.012% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 912.543% |
Sunny Pharmtech Inc. | 120.87 Million TWD | -469.811% |
Lin BioScience, Inc. | -3.21 Billion TWD | 121.401% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 316.981% |
Feng Chi Biotech Corp. | -19.81 Million TWD | 3576.182% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | -2065.224% |
Lukas Biomedical Inc. | 50.75 Million TWD | -1256.982% |
RBC Bioscience Corporation | 422.18 Million TWD | -63.136% |
BiOptic Inc. | 12.59 Million TWD | -5369.632% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 172.928% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 778.651% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 516.971% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | -118.735% |
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 993.952% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 362.294% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -2152.391% |
Neith Corporation | -150.31 Million TWD | 558.207% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 1170.779% |
NaviFUS Corp. | -123.12 Million TWD | 659.361% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | -830.083% |
Sinew Pharma Inc. | -160.34 Million TWD | 529.534% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 384.728% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 304.146% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 266.91% |
AP Biosciences Inc | -196.52 Million TWD | 450.452% |
3D Global Biotech Inc. | -11.43 Million TWD | 6121.999% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 183.011% |
Intech Biopharm Corporation | 1.35 Billion TWD | 49.258% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 266.009% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 429.007% |
TWi Biotechnology, Inc. | -143.86 Million TWD | 578.744% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 308.366% |
TCI GENE Inc. | -689.25 Million TWD | 199.925% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 679.071% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 152.607% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -3262.476% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 776.093% |
PharmaEngine, Inc. | -860.8 Million TWD | 180.01% |
Savior Lifetec Corporation | -812.54 Million TWD | 184.763% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 329.603% |
OBI Pharma, Inc. | -398.22 Million TWD | 272.952% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 288.478% |
Acepodia, Inc. | -6.02 Billion TWD | 111.44% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 120.247% |